AzTrials
AzTrials

Individuals With C6-C7 Tetraplegia (AIS A or B)TETRAMINFNCT03190863

Grasping Rehabilitation Using Motor Imagery With or With no Neurofeedback After Tetraplegia

A study testing Motor imagery combined with neurofeedback (MINF) and Motor imagery (MI) in people with Individuals With C6-C7 Tetraplegia (AIS A or B), run by Hospices Civils de Lyon at 2 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Motor imagery has shown promising results to optimize tenodesis grasp in individuals with C6-C7 tetraplegia. However, efficacy of using motor imagery to improve grasping after tetraplegia requires further study with higher level of evidence. Read more about this study

Who is it for?
Ages 18 to 55 years
What is being tested?
Motor imagery combined with neurofeedback (MINF) and Motor imagery (MI)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
21 participants
Where
2 sitesFrance
Study dates
29 Mar 2018to 29 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Volunteer individuals with C6-C7 tetraplegia with complete finger flexor paralysis restricting grasping capabilities to the tenodesis.
  • Consent to participate to the study after receiving clear, loyal and appropriate information.
  • Aged between 18 and 55 years.
  • Time since spinal cord injury above 6 months
  • Stabilized condition in particular sensori-motor deficit.
  • Sitting position for more than 1 hour
  • Able to imagine movement
  • Health care beneficiary

Who cannot join

  • Long-lasting autonomic disorders while sitting (orthostatic hypotension and/or blood pressure instability) limiting sitting position to less than 1 hour.
  • Upper limb pain for either mechanic or neuropathic reasons preventing all grasping movement and/or the ability to imagine those movements.
  • Restricted wrist and finger range of motion preventing the tenodesis grasp.
  • Patient after surgical tendon transfer that improved grasping capabilities (e.g. active finger flexion).
  • Ongoing participation in another research that aim to evaluate an intervention likely to improve the neurological or functional recovery introducing an experimental bias.
  • Specific contraindication to Magnetoencephalography with the presence of metallic fragments inside the body such as pace-maker, neurostimulator, cochlear implants, steel dental implant and osteosynthesis material only applicable to the participants included in Lyon hospital center (n=15).

Trial locations and contacts

2 sites in 1 country.

France2 sites, 2 recruiting
  • Le Centre Mutualiste Neurologique PROPARA, Parc Euromédecine

    Montpellier, 34090

    Anthony GELIS, MD, a.gelis@propara.fr

    Anthony GELIS, MD

    Recruiting
  • Service de médecine physique et de réadaptation, Hôpital Henry Gabrielle

    Saint-Genis-Laval, 69230

    Sébastien MATEO, ext-sebastien.mateo@chu-lyon.fr

    Gilles RODE, MD

    Recruiting

Other trials in France

About this study

Official title: Investigating the Effect of Motor Imagery With or With no Visual Neurofeedback on Grasping Capabilities After C6-C7 Tetraplegia: a Multicentric Randomized Controlled Trial.

Motor imagery has shown promising results to optimize tenodesis grasp in individuals with C6-C7 tetraplegia. However, efficacy of using motor imagery to improve grasping after tetraplegia requires further study with higher level of evidence. In addition, controlling covert practice remains difficult due to the absence of overt movements. However, similar brain activity measured during both over and cover movements makes possible to provide visual information about the covert practice performance using neurofeedback.

The Investigators thus designed this multicentric randomized controlled trial to investigate the effect of motor imagery with or with no visual neurofeedback on grasping capabilities after C6-C7 tetraplegia. They hypothesized that providing neurofeedback based on brain activity measured by electroencephalography namely knowing the covert practice performance would results in greater grasping improvement in response to practice as compared to motor imagery practice alone.

Being tested
Motor imagery combined with neurofeedback (MINF), Motor imagery (MI), Control (C)
Keywords
Tenodesis grasp, Neurofeedback, Motor imagery, Reach-to-grasp, Rehabilitation, Physical therapy, Cervical spinal cord injury, Tetraplegia, AIS A, AIS B
Medical subject headings
Quadriplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motor imagery combined with neurofeedback (MINF)Behavioural

    7 individuals with C6-C7 tetraplegia randomize in the experimental group consisting in motor imagery practice combined with visual neurofeedback (NF - i.e. performance of the imagined movement).

    Intervention consists in a total of 15 sessions repeated 3 times a week and lasting 5 weeks. Each session will last 45 minutes. An experienced physical therapist supervised all sessions. After each imagined movement, the NF based on brain activity measured by electroencephalography is display on a screen.

  • Motor imagery (MI)Behavioural

    7 individuals with C6-C7 tetraplegia randomized in the active comparator group consisting in motor imagery practice alone without visual NF. This means that the performance of the imagined movement is not displayed to the participants.

    Intervention consists in a total of 15 sessions repeated 3 times a week and lasting 5 weeks. Each session will last 45 minutes. An experienced physical therapist supervised all sessions.

  • Control (C)Behavioural

    7 individuals with C6-C7 tetraplegia randomized in the sham comparator group consisting in imagining geometric shapes by visualization. Shapes are successively displayed on a screen.

    Intervention consists in a total of 15 sessions repeated 3 times a week and lasting 5 weeks. Each session will last 45 minutes. An experienced physical therapist supervised all sessions.

Study groups in NCT03190863
Study groupRoleWhat they receive
Motor imagery combined with neurofeedback (MINF)ExperimentalNot described
Receives: Behavioral: Motor imagery combined with neurofeedback (MINF)
Motor imagery (MI)Active comparatorNot described
Receives: Behavioral: Motor imagery (MI)
Control (C)Sham comparatorNot described
Receives: Behavioral: Control (C)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wrist extension angle in degree during grasping with 3D motion analysis system

    Individuals with C6-C7 tetraplegia extend their wrist to grasp using tenodesis. Specifically, the wrist extension shortens the tendons of fingers and thumbs flexors that elicit either a palmar or a lateral grip. A complete reach-to-grasp movement will be recorded using a 3D motion analysis system (Vicon Motion Systems Ltd. UK). Wrist extension angle in degree will be measure during grasping when the object is grasped.

    Measured: Up to 19 weeks

Secondary outcomes (13)
  1. Temporal kinematic parameters of reach-to-grasp movements with 3D motion analysis system (Vicon Motion Systems Ltd. UK).

    Computation of temporal kinematic parameters (e.g. movement duration) measured during a complete reach-to-grasp movement using a 3D motion analysis system (Vicon Motion Systems Ltd. UK). Temporal parameters are also aggregated with spatial parameters.

    Measured: Up to 19 weeks

  2. Spatial kinematic parameters of reach-to-grasp movements with 3D motion analysis system (Vicon Motion Systems Ltd. UK).

    Computation of spatial kinematic parameters (e.g. movement trajectory) measured during a complete reach-to-grasp movement using a 3D motion analysis system (Vicon Motion Systems Ltd. UK).Spatial parameters are also aggregated with temporal parameters.

    Measured: Up to 19 weeks

  3. Brain activity change in response to intervention using magnetoencephalography

    Brain activity will be measured during upper limb movement (e.g. a complete reach-to-grasp movement) using magnetoencephalography. The device is only available in Lyon Hospital. Correspondingly, fifteen participants included in Lyon Hospital will achieve this measure.

    Measured: Up to 19 weeks

  4. passive upper limb range of motion (ROM) measured using goniometer and/or inclinometer

    This outcome will be measured using goniometer and/or inclinometer by the same blind and experienced physical therapist

    Measured: Up to 19 weeks

  5. Upper limb strength measured using the hand held dynamometer

    This outcome will be measured using the manual muscle test and the hand held dynamometer by the same blind and experienced physical therapist.

    Measured: Up to 19 weeks

  6. Upper limb strength measured using the manual muscle test

    This outcome will be measured using the manual muscle test and the hand held dynamometer by the same blind and experienced physical therapist.

    Measured: Up to 19 weeks

  7. Hand dexterity measured using the Box and Block test

    This outcome will be measured using i) the Box and Block Test, ii) the Nine Hole Peg Test, iii) the Jebsen Test and iv) the Capability of Upper Limb Test supervised by the same blind and experienced occupational therapist

    Measured: Up to 19 weeks

  8. Hand dexterity measured using the Nine Hole Peg test

    This outcome will be measured using i) the Box and Block Test, ii) the Nine Hole Peg Test, iii) the Jebsen Test and iv) the Capability of Upper Limb Test supervised by the same blind and experienced occupational therapist

    Measured: Up to 19 weeks

  9. Hand dexterity measured using the Jebsen test

    This outcome will be measured using i) the Box and Block Test, ii) the Nine Hole Peg Test, iii) the Jebsen Test and iv) the Capability of Upper Limb Test supervised by the same blind and experienced occupational therapist

    Measured: Up to 19 weeks

  10. Hand dexterity measured using the Capability of Upper Limb test

    This outcome will be measured using i) the Box and Block Test, ii) the Nine Hole Peg Test, iii) the Jebsen Test and iv) the Capability of Upper Limb Test supervised by the same blind and experienced occupational therapist

    Measured: Up to 19 weeks

  11. Quality of Life measured using the WHOQOL-Bref

    This outcome will be measured using the WHOQOL-Bref by the same blind and experienced physical therapist.

    Measured: Up to 19 weeks

  12. Daily life autonomy measured using the Quadriplegic Index of Function

    This outcome will be measured using the Quadriplegic Index of Function by the same blind and experienced physical therapist.

    Measured: Up to 19 weeks

  13. Motor imagery capability measured by the Kinesthetic Visual Imagery Questionnaire

    Motor imagery capability will be measured by the Kinesthetic Visual Imagery Questionnaire by the same blind and experienced physical therapist along with comparing overt and covert movement duration, galvanic skin response, electroencephalography activity.

    Measured: Up to 19 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2017
  2. Study start29 Mar 2018
  3. Primary completion29 May 2025 (estimated)
  4. Study completion29 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
21 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03190863
Sponsor's protocol ID
69HCL17_0016
Acronym
TETRAMINF
Status last verified
Sep 2023
First submitted
25 Apr 2017
Last updated
29 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data will be shared after deidentification (but only the data required for the new analysis will be transmitted). This includes for each visit and each participant averaged data of wrist extension angle during grasping of a single upper limb measured in degree with 3D motion analysis system. This includes for each visit, each participant and each upper limb: * Box and Block test * Nine Hole Peg test * hand held dynamometer for each of 4 muscles This includes for each visit and each participant the total score of: * manual muscle testing of the upper limb key muscles as defined by the ASIA score for each arm * Capability of Upper Limb * WHOQOL-Bref * Quadriplegic Index of Function * Kinesthetic Visual Imagery Questionnaire This also includes for each visit and each participant the passive range of motion expressed in degree and measured using goniometer for shoulder, elbow and wrist. This do not include electrophysiological measurements.

Publications

  • Mateo S, Di Rienzo F, Reilly KT, Revol P, Delpuech C, Daligault S, Guillot A, Jacquin-Courtois S, Luaute J, Rossetti Y, Collet C, Rode G. Improvement of grasping after motor imagery in C6-C7 tetraplegia: A kinematic and MEG pilot study. Restor Neurol Neurosci. 2015;33(4):543-55. doi: 10.3233/RNN-140466.

    PubMed 26409412
  • Charbonnier G, Reilly KT, Schwartz D, Daligault S, Luaute J, Rossetti Y, Collet C, Gelis A, Rode G, Mateo S. Grasping rehabilitation using motor imagery with or without neurofeedback after tetraplegia: a study protocol for a bicentric randomised controlled trial. BMJ Open. 2024 Oct 21;14(10):e074652. doi: 10.1136/bmjopen-2023-074652.

    PubMed 39433413

Questions about this trial

What is this clinical trial studying?

A study testing Motor imagery combined with neurofeedback (MINF) and Motor imagery (MI) in people with Individuals With C6-C7 Tetraplegia (AIS A or B), run by Hospices Civils de Lyon at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sébastien MATEO, PhD (478 865 066 ext. +33, sebastien.mateo@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Wrist extension angle in degree during grasping with 3D motion analysis system (time frame: Up to 19 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03190863, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in